Innovative Journal of Pediatrics
The Scientific Journal of Growth & Development Research Center
CrossRef
Works that cite this article, indexed by Crossref.
Efficacy and safety of drugs for attention deficit hyperactivity disorder in children and adolescents: a network meta-analysis
European Child & Adolescent Psychiatry 27(10) (2018)
Sarah C. O. S. Padilha; Suzane Virtuoso; Fernanda S. Tonin; Helena H. L. Borba; Roberto Pontarolo
Efficacy of stimulants for preschool attention‐deficit/hyperactivity disorder: A systematic review and meta‐analysis
JCPP Advances 3(3) (2023)
Luisa S. Sugaya; Luis C. Farhat; Pietro Califano; Guilherme V. Polanczyk
Diagnosis and Treatment Options for Preschoolers with Attention-Deficit/Hyperactivity Disorder
Journal of Child and Adolescent Psychopharmacology 30(2) (2020)
Sharon Wigal; Phillip Chappell; Donna Palumbo; Shannon Lubaczewski; Sara Ramaker; Richat Abbas
A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders
Expert Opinion on Pharmacotherapy 24(13) (2023)
Arnaud Pouchon; Rayan Nasserdine; Clément Dondé; Antoine Bertrand; Mircea Polosan; Stéphanie Bioulac
Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies
Cochrane Database of Systematic Reviews (2018)
Ole Jakob Storebø; Nadia Pedersen; Erica Ramstad; Maja Laerke Kielsholm; Signe Sofie Nielsen; Helle B Krogh; Carlos R Moreira-Maia; Frederik L Magnusson; Mathilde Holmskov; Trine Gerner; Maria Skoog; Susanne Rosendal; Camilla Groth; Donna Gillies; Kirsten Buch Rasmussen; Dorothy Gauci; Morris Zwi; Richard Kirubakaran; Sasja J Håkonsen; Lise Aagaard; Erik Simonsen; Christian Gluud
Safety and tolerability of antipsychotic agents in neurodevelopmental disorders: a systematic review
Expert Opinion on Drug Safety 19(11) (2020)
Felice Iasevoli; Annarita Barone; Elisabetta Filomena Buonaguro; Licia Vellucci; Andrea de Bartolomeis
The effect of metilpheniydate, risperidone and combination therapy on ECG in children with attention-deficit hyperactivity disorder
Journal of Electrocardiology 50(4) (2017)
Derya Karpuz; Olgu Hallioglu; Fevziye Toros; Bahar Tasdelen
Atypical antipsychotics for Attention-Deficit/Hyperactivity disorder- science, art, or fad?
European Psychiatry 62 (2019)
Ahmed Naguy; Mohamed S Hashem; Sulaiman AlKhadhar
Children with ADHD and symptoms of oppositional defiant disorder improved in behavior when treated with methylphenidate and adjuvant risperidone, though weight gain was also observed – Results from a randomized, double-blind, placebo-controlled clinical trial
Psychiatry Research 251 (2017)
Leila Jahangard; Shahrokh Akbarian; Mohammad Haghighi; Mohammad Ahmadpanah; Amir Keshavarzi; Hafez Bajoghli; Dena Sadeghi Bahmani; Edith Holsboer-Trachsler; Serge Brand
DAT1 Gene Polymorphism in Children with Attention Deficit Hyperactivity Disorder
Iranian Journal of Pediatrics 28(3) (2018)
Seyed - Mahmoud Tabatabaei; Shahrokh Amiri; Nasrin Forghani; Seyed - Gholamreza Noorazar; Shahin Abdollahi - Fakhim; Habibeh Barzegar; Mir - Mahmoud Mirnasab
Diagnosis and Treatment of Attention-Deficit/Hyperactivity Disorder in Preschool-Aged Children
Journal of Child and Adolescent Psychopharmacology 28(9) (2018)
Ann C. Childress; Jeffrey G. Stark
Innovative therapeutic strategies using ADHD medications tailored to the behavioral characteristics of patients with chronic pain
Frontiers in Pharmacology 16 (2025)
Satoshi Kasahara; Miwako Takahashi; Takashi Suto; Taito Morita; Hideaki Obata; Shin-Ichi Niwa
Pharmacotherapy of attention-deficit hyperactivity disorder: common quandaries, dilemmas and challenges
International Clinical Psychopharmacology 35(6) (2020)
Mariela Mosheva; Nina Dar; Lee Rima Madi; Abraham Weizman; Doron Gothelf
Cancellation of outpatient appointments in patients with attention-deficit/hyperactivity disorder
PLOS ONE 16(11) (2021)
Kensuke Nomura; Ryosuke Tarumi; Kazunari Yoshida; Mitsuhiro Sado; Takefumi Suzuki; Masaru Mimura; Hiroyuki Uchida; Kazutaka Ikeda
Risperidone for children with attention-deficit/hyperactivity disorder and severe behavioral dysregulation: a randomized placebo-controlled assessor-blinded trial
BMC Psychiatry 26(1) (2026)
Ezatollah Abbasi; Alireza Abdi; Rana Eskandari
A Comparative Study of Risperidone and Aripiprazole in Attention Deficit Hyperactivity Disorder in Children Under Six Years Old: A Randomized Double-Blind Study
Iranian Journal of Pediatrics 28(1) (2018)
Katayoon Razjouyan; Arash Danesh; Mojgan Khademi; Rozita Davari-Ashtiani; Simasadat Noorbakhsh
Symptom scores and medication treatment patterns in children with ADHD versus autism
Psychiatry Research 288 (2020)
Susan D. Mayes; James G. Waxmonsky; Raman Baweja; Richard E. Mattison; Hasan Memon; Melanie Klein; Usman Hameed; Daniel Waschbusch
11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology
Psychiatry and Clinical Psychopharmacology 29(sup1) (2019)
Pharmacotherapy for Preschool Children with Attention Deficit Hyperactivity Disorder (ADHD): Current Status and Future Directions
CNS Drugs 35(4) (2021)
Jonathan R. Young; Adare Yanagihara; Rachel Dew; Scott H. Kollins
Okul Öncesi Dönemde Psikiyatrik İlaç Tedavisi Başlanan Hastaların İlaç Tedavisinden Fayda Görmeleri ve Yan Etkiler Açısından Retrospektif Taranması
Turkish Journal of Pediatric Disease 15(4) (2021)
Dilek Ünal; Kevser Nalbant; Dilek Ünal; Mine Aybı
ADHD-A Clinician’s Bird’s Eye View of Current Status and New Vistas!
Psychopharmacology Bulletin 53(1) (2025)
Ahmed Naguy; Saxby Pridmore; Salem Alwetayan; Dalal Elsori; Bibi Alamiri
Attention Deficit Hyperactivity Disorder in Preschool-Age Children
Child and Adolescent Psychiatric Clinics of North America 26(3) (2017)
Mini Tandon; Alba Pergjika